 Clinical use biologic response modifiers cancer treatment overview Part II Colony-stimulating factors Colony-stimulating factors CSFs hematopoietic growth hormones production maturation function white blood cells granulocyte-macrophage CSF GM-CSF granulocyte CSF G-CSF recombinant DNA technology Clinical indications agents bone marrow failure secondary administration chemotherapeutic drugs radiation bone marrow transplantation variety congenital iatrogenic neutropenias Toxicity usual clinical doses mild bone pain constitutional symptoms fever headache myalgias lymphokine multiplication several types killer cells cells foreign substances tumors normal cells Major applications treatment patients renal cell carcinoma overall objective response rate percent malignant melanoma response rates percent Combination therapy biologics conventional cytotoxic drugs efficacy tumors Toxicity severe reversible Hemodynamic toxicity hypotension edema gain renal function characteristic Suggestions pharmacologic management toxicities